General form of registration statement for all companies including face-amount certificate companies

Nature of Business and Significant Accounting Policies (Details)

v3.21.2
Nature of Business and Significant Accounting Policies (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 23, 2019
Feb. 28, 2021
Feb. 29, 2020
Feb. 28, 2021
Feb. 29, 2020
May 31, 2020
May 31, 2019
Jun. 01, 2019
Jun. 27, 2018
May 31, 2018
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable       $ 1,544,291 $ 325,000 $ 1,682,278 $ 0      
Asset Impairment Charges   $ 2,498,706 $ 0 2,498,706   0 0      
Financing Receivable, after Allowance for Credit Loss   0   0            
Interest Receivable, Current   0   0   3,322 0      
Cash and Cash Equivalents, at Carrying Value   2,231,934 3,039,095 2,231,934 3,039,095 2,925,568 10,525,791     $ 52,964
Accounts Receivable, Credit Loss Expense (Reversal)   0 0 5,927 0 108,392 0      
Goodwill, Impairment Loss   0 0 0 0 25,185,003 0      
Goodwill   557,896   557,896   557,896 25,742,899   $ 25,742,899  
Advertising Expense   383,128 220,927 826,867 424,019 $ 836,000 1,655,374      
Research and Development Expense   8,334 $ 0 $ 20,726 $ 0   $ 0      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)       87,861,815 87,577,583 88,130,526 86,439,117      
Operating Lease, Right-of-Use Asset   1,136,695   $ 1,136,695   $ 1,403,429 $ 0 $ 2,703,821    
Operating Lease, Liability   1,158,740   1,158,740   1,473,051 $ 2,675,310 $ 2,675,310    
CannAssist LLC [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable $ 342,567                  
Financing Receivable, after Allowance for Credit Loss   $ 0   0   $ 0        
Principal [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Asset Impairment Charges       2,497,884            
Accrued Interest [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Asset Impairment Charges       $ 822            
Warrant [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)       54,410,145 54,835,145 54,835,145 54,818,985      
Equity Unit Purchase Agreements [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)       7,676,974 7,676,974 7,676,974 7,676,974      
Convertible Debt Securities [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)       25,454,696 24,678,796 25,131,739 23,261,393      
Stock Payable [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)       320,000 386,668 486,668 681,764      
Notes Receivable [Member] | Principal [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable       $ 2,901,569            
Notes Receivable [Member] | Accrued Interest [Member]                    
Nature of Business and Significant Accounting Policies (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable       $ 220,196